Logo

BAK

Braskem S.A.

BAK

Braskem S.A. NYSE
$2.89 0.00% (+0.00)

Market Cap $1.15 B
52w High $5.26
52w Low $2.32
Dividend Yield 0%
P/E -1.17
Volume 369.80K
Outstanding Shares 398.48M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $17.299B $1.365B $-26M -0.15% $-0.065 $-1.021B
Q2-2025 $17.857B $1.32B $-267M -1.495% $-0.66 $2.361B
Q1-2025 $19.46B $1.211B $698M 3.587% $1.76 $3.256B
Q4-2024 $19.152B $1.448B $-5.646B -29.48% $-14.18 $-1.061B
Q3-2024 $21.265B $1.23B $-593M -2.789% $-1.48 $1.083B

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $7.408B $87.383B $90.556B $-3.533B
Q2-2025 $10.304B $91.303B $94.561B $-3.805B
Q1-2025 $13.029B $95.422B $99.217B $-4.236B
Q4-2024 $16.772B $101.575B $105.853B $-4.782B
Q3-2024 $14.337B $92.65B $94.143B $-25M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-26M $-683M $-1.057B $-732M $-2.52B $-1.951B
Q2-2025 $-267M $-285M $-696M $-1.039B $-2.134B $-933M
Q1-2025 $698M $-2.332B $-576M $-191M $-3.669B $-2.985B
Q4-2024 $-8.329B $817M $-1.017B $2.386B $3.067B $-215M
Q3-2024 $-1.312B $-790M $-629M $-637M $-2.294B $-1.63B

Five-Year Company Overview

Income Statement

Income Statement Braskem’s income statement shows a classic boom‑and‑bust pattern. A few years ago the company enjoyed very strong margins and profits, but since then earnings have swung sharply into losses. Revenue has come down from prior peaks, and profit margins have compressed significantly versus the very strong pandemic‑era cycle. Operating profit has only recently turned slightly positive again after a loss, but this has not been enough to offset heavy below‑the‑line impacts, leading to sizable net losses in most recent years. Overall, the business is still large and active, but profitability has been volatile and currently sits well below its past high points, typical of a cyclical chemicals producer under pressure from weaker spreads, currency swings, and input costs.


Balance Sheet

Balance Sheet The balance sheet reflects a highly leveraged and stressed capital structure. Total assets have grown gradually, and cash on hand has stayed fairly stable, which provides some liquidity cushion. However, debt has climbed meaningfully in recent years, and shareholders’ equity has flipped back into negative territory after a short period in positive ground. Negative equity signals that accumulated losses and other adjustments have eroded the capital base, leaving the company reliant on debt and cash flow to support operations. In simple terms, Braskem carries a heavy debt load with a thin equity buffer, which heightens sensitivity to any prolonged downturn in profitability.


Cash Flow

Cash Flow Cash generation has mirrored the earnings cycle. During the stronger phase of the cycle, Braskem produced solid operating cash flow and healthy free cash flow after investments. More recently, cash from operations has weakened sharply, even turning negative at one point, and free cash flow has been negative for two consecutive years. The company continues to invest steadily in its asset base, which is positive for long‑term competitiveness but puts additional pressure on cash in a downturn. The pattern suggests a business that can generate strong cash in good markets but currently faces a tighter cash position and greater need to balance investment with debt servicing and working‑capital demands.


Competitive Edge

Competitive Edge Competitively, Braskem holds a strong strategic position despite its financial volatility. It is the largest producer of thermoplastic resins in the Americas, with integrated operations that stretch from feedstock to final resins and specialty chemicals. This scale and integration can bring cost advantages, logistical efficiencies, and deep relationships with large industrial customers. Its global footprint across Brazil, North America, Mexico, and Europe helps diversify markets, though it also adds exposure to regional demand swings and regulatory regimes. A key differentiator is its early and visible commitment to sustainable plastics, where branded bio‑based and recycled offerings give it a distinct profile versus more conventional petrochemical peers. The main competitive risks are the inherently cyclical nature of the industry, exposure to volatile feedstock prices, and increasing environmental and regulatory scrutiny on plastics and emissions.


Innovation and R&D

Innovation and R&D Braskem stands out in its sector for a clear innovation and sustainability agenda. Its flagship bio‑based plastics line and its recycled “Wenew” portfolio position the company as a leader in low‑carbon and circular solutions, not just a commodity producer. It has built dedicated innovation centers and labs to co‑develop applications with customers, especially in packaging and specialty uses, which helps lock in relationships and capture premium niches. On the technology side, Braskem is actively deploying digital tools and artificial intelligence across its plants to improve process optimization, quality control, and product development. Partnerships with research institutions and technology companies, along with a new renewable innovation center in the United States, broaden its access to cutting‑edge science in biomass, advanced recycling, and potential carbon‑neutral feedstocks. The opportunity is that these efforts can gradually shift the mix toward higher‑value, more resilient products, though it will likely take time before they materially offset the economic swings of the core petrochemical business.


Summary

Overall, Braskem combines strong industrial scale and visible innovation leadership with a currently challenged financial picture. The company operates in a volatile, cyclical industry and has recently moved from a period of exceptional profitability to sustained losses, which, together with higher debt, has strained its balance sheet and free‑cash‑flow profile. At the same time, its competitive strengths—regional scale, integrated assets, technology capabilities, and an early lead in sustainable and recycled plastics—give it strategic options that many peers may lack. Going forward, key aspects to watch are the recovery of margins in its core resin and chemicals business, the company’s ability to stabilize cash generation and manage leverage, and the pace at which its sustainable and specialty offerings grow as a share of the portfolio. How well Braskem can bridge the near‑term financial pressures while advancing its innovation and circular‑economy strategy will largely shape its longer‑term trajectory.